Pramipexole Quick Detail:
Product Name: Pramipexole
Synonyms: Mirapex, Mirapexin, Sifrol
CAS Number: 104632-26-0
Molecular Weight: 211.324 g/mol
Molecular Formula: C10H17N3S
Appearance: white crystalline powder
Density: 1.17 g/cm3
Melting Point: 288-290 °C
Boiling Point: 378 °C at 760 mmHg
Flash Point: 182.4 °C
Pramipexole is a non-ergoline dopamine agonist indicated for treating early-stage Parkinson’s disease (PD) and restless legs syndrome (RLS). It is also sometimes used off-label as a treatment for cluster headache and to counteract the problems with sexual dysfunction experienced by some users of the selective serotonin reuptake inhibitor (SSRI) antidepressants. Pramipexole has shown robust effects on pilot studies in a placebo-controlled proof of concept study in bipolar disorder. It is also being investigated for the treatment of clinical depression and fibromyalgia.
Pramipexole (INN, trade names Mirapex and Sifrol) is a medication indicated for treating Parkinson’s disease and restless legs syndrome (RLS). It is also sometimes used off-label as a treatment for cluster headache or to counteract the problems with low libido experienced by some users of SSRI antidepressant drugs. Pramipexole has shown robust effects on pilot studies in bipolar disorder. Pramipexole is classified as a non-ergoline dopamine agonist.